Professor, Medicine, UCSF School of Medicine
Internal Medicine
Dr. Michael A. Matthay, MD
|
|
Give Review
Michael Matthay is an expert in the field of Internal Medicine. He studied medicine at Perelman School of Medicine at the University of Pennsylvania. Michael Matthay is a published doctor as well. He has 102 publications published. The latest was: Acute Hypoxemic Respiratory Failure after Large-Volume Thoracentesis. Mechanisms of Pleural Fluid Formation and Reexpansion Pulmonary Edema. Michael A. Matthay accepts all Medicare patients.
Publications
- Cigarette smokers have exaggerated alveolar barrier disruption in response to lipopolysaccharide inhalation.
- New Strategies for Effective Therapeutics in Critically Ill Patients.
- Plasma angiopoietin-2 outperforms other markers of endothelial injury in prognosticating pediatric ARDS mortality.
- The acute respiratory distress syndrome following isolated severe traumatic brain injury.
- Estimating Dead-Space Fraction for Secondary Analyses of Acute Respiratory Distress Syndrome Clinical Trials.
- Plasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome.
- Erratum to: Plasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome.
- Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions.
- Proteolytic Regulation of Epithelial Sodium Channels by Urokinase Plasminogen Activator: CUTTING EDGE AND CLEAVAGE SITES.
- Body temperature and mortality in patients with acute respiratory distress syndrome.
- Biology and pathology of fibroproliferation following the acute respiratory distress syndrome.
- Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: a randomized clinical trial.
- Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury.
- A Multicenter Study of Key Stakeholders' Perspectives on Communicating with Surrogates about Prognosis in ICUs.
- Recipient clinical risk factors predominate in possible transfusion-related acute lung injury.
- Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.
- Endogenous and Exogenous Cell-Based Pathways for Recovery from Acute Respiratory Distress Syndrome.
- Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis.
- The Association Between Physiologic Dead-Space Fraction and Mortality in Subjects With ARDS Enrolled in a Prospective Multi-Center Clinical Trial.
- Silencing Bruton's tyrosine kinase in alveolar neutrophils protects mice from LPS/immune complex-induced acute lung injury.
- Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.
- Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy.
- Translational studies in the ex vivo human lung.
- Prevalence and Impact of Active and Passive Cigarette Smoking in Acute Respiratory Distress Syndrome.
- Applying metabolomics to uncover novel biology in ARDS.
- Resolution of pulmonary edema. Thirty years of progress.
- Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia.
- Correspondence to: Soliciting Strategies for Developing Cell-Based Reference Materials to Advance Mesenchymal Stem/Stromal Cell Research and Clinical Translation.
- Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.
- Mechanical ventilation in acute hypoxemic respiratory failure: A review of new strategies for the practicing hospitalist.
- Prospective Study on the Clinical Course and Outcomes in Transfusion-Related Acute Lung Injury.
- Conditioned media from mesenchymal stromal cells restores sodium transport and preserves epithelial permeability in an in vitro model of acute alveolar injury.
- Mesenchymal stromal (stem) cell therapy: an emerging immunomodulatory strategy for the adjunctive treatment of sepsis.
- Treating ARDS: new hope for a tough problem.
- TGF-β and lung fluid balance in ARDS.
- Reperfusion pulmonary edema in children with tetralogy of Fallot, pulmonary atresia, and major aortopulmonary collateral arteries undergoing unifocalization procedures...
- Sugar administration is an effective adjunctive therapy in the treatment of Pseudomonas aeruginosa pneumonia.
- Prognostic and Diagnostic Value of Plasma Soluble Suppression of Tumorigenicity-2 Concentrations in Acute Respiratory Distress Syndrome.
- Viral Pathogens and Acute Lung Injury: Investigations Inspired by the SARS Epidemic and the 2009 H1N1 Influenza Pandemic.
- Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation*.
- Cell Therapy for Lung Diseases: Report from an NIH-NHLBI Workshop November 13-14, 2012.
- Noradrenergic Neurons Regulate Monocyte Trafficking and Mortality during Gram-Negative Peritonitis in Mice.
- The Berlin Definition of ARDS versus Pathological Evidence of Diffuse Alveolar Damage.
- Activation of the heat shock response attenuates the interleukin 1?-mediated inhibition of the amiloride-sensitive alveolar epithelial ion transport.
- Regulation and repair of the alveolar-capillary barrier in acute lung injury.
- Dysfunction of inflammation-resolving pathways is associated with exaggerated postoperative cognitive decline in a rat model of the metabolic syndrome.
- Risk Factors and Outcomes in Transfusion-associated Circulatory Overload.
- Therapeutic Effects of Human Mesenchymal Stem Cells In Ex Vivo Human Lungs Injured with Live Bacteria.
- Hyperoxic acute lung injury.
- From protective ventilation to super-protective ventilation for acute respiratory distress syndrome.
- Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients.
- IL-8 inhibits cAMP-stimulated alveolar epithelial fluid transport via a GRK2/PI3K-dependent mechanism.
- Beta-Adrenergic Receptor Polymorphisms and Cardiac Graft Function in Potential Organ Donors.
- Pathogenetic and Predictive Value of Biomarkers in Patients with ALI and Lower Severity of Illness: Results from two clinical trials.
- The 4G/4G Genotype of the PAI-1 (Serpine-1) 4G/5G Polymorphism Is Associated With Decreased Lung Allograft Utilization.
- Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis.
- Clinical review: Early treatment of acute lung injury - paradigm shift toward prevention and treatment prior to respiratory failure.
- Plasma angiopoietin-2 in clinical acute lung injury: Prognostic and pathogenetic significance*
- Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential.
- Progress in modelling acute lung injury in a pre-clinical mouse model.
- Cell-based Therapy for Acute Lung Injury: Are We There Yet?
- Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia.
- Altered lymphatics in an ovine model of congenital heart disease with increased pulmonary blood flow.
- Transfusion related acute lung injury: incidence and risk factors.
- Perspective on the Journal - 2006-2011.
- Prognostic value of pulmonary dead space in patients with the acute respiratory distress syndrome.
- Acute lung failure.
- Physiology, Reductionism and Translational Medicine: The Right Mix.
- Clinical review: Thinking outside the box - an iconoclastic view of current practice.
- Claudin-4 Levels Are Associated with Intact Alveolar Fluid Clearance in Human Lungs.
- Mesenchymal stem cells and acute lung injury.
- Proteomic Analysis of Pulmonary Edema Fluid from Patients with ALI/ARDS Reveals a Prominence of Intracellular Proteins.
- Con: corticosteroids are not indicated for treatment of acute lung injury from H1N1 viral pneumonia.
- Decreased respiratory system compliance on the sixth day of mechanical ventilation is a predictor of death in patients with established acute lung injury.
- Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors.
- Alveolar Epithelial Cells Express Mesenchymal Proteins in Patients With Idiopathic Pulmonary Fibrosis.
- Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury.
- Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells.
- The influence of race on the development of acute lung injury in trauma patients.
- Neuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury.
- Active and Passive Cigarette Smoking and Acute Lung Injury Following Severe Blunt Trauma.
- The acute respiratory distress syndrome: pathogenesis and treatment.
- Role of CFTR expressed by neutrophils in modulating acute lung inflammation and injury in mice.
- Informed consent in research to improve the number and quality of deceased donor organs.
- Priming with endotoxin increases acute lung injury in mice by enhancing the severity of lung endothelial injury.
- Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients.
- Stem cells in sepsis and acute lung injury.
- Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37.
- Mesenchymal stem cells for acute lung injury: preclinical evidence.
- Thinking outside the box: Introduction.
- Therapeutic potential of mesenchymal stem cells for severe acute lung injury.
- Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients.
- Advances and challenges in translating stem cell therapies for clinical diseases.
- Pathophysiology of transfusion-related acute lung injury.
- Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1.
- Alveolar fluid clearance is faster in women with acute lung injury compared to men.
- Acute respiratory distress syndrome after surgery: can the risk be decreased?
- Acute lung injury: epidemiology, pathogenesis, and treatment.
- Therapeutic strategies for severe acute lung injury.
- Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.
- Acute Hypoxemic Respiratory Failure after Large-Volume Thoracentesis. Mechanisms of Pleural Fluid Formation and Reexpansion Pulmonary Edema.
Schools
Perelman School of Medicine University of Pennsylvania
University Colo Med Center
Ucsf Med Center
Doctors Specialties
- Critical Care Medicine
- Pulmonology
- Internal Medicine
Accepted Insurances
- Aetna HMO
- Basic HMO
- Choice Plus POS II
- Vitalidad Plus California Con Aetna
- Blue Card PPO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Covered California - Bronze PPO
- Health Net PPO
- Individual and Family PPO
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Education
-
University of Colorado -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891734497 |
| Last Name Of The Provider | MATTHAY |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Richard M. Dennes, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eliza H. McCaw, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William M. Strull, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Warren S. Browner, MD |
|
|
Dr. Paul M. Johnson, MD |
|
|
Dr. Margaret B. Wheeler, MD |
|
|
Dr. Edgar Pierluissi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David R. Warren, MD |
|
|
Dr. Olga M. Fortenko, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodora K. Nicholau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan S. Yoo, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edmund Tsoi, MD
This Doctor is OpenDoctor Recommended.
|